UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib

Anti-cancer drugs, 2010-01, Vol.21 Suppl 1 (Supplement 1), p.S3-S11

2010

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

International Journal of Endocrinology, 2010-01, Vol.2010, p.1-14

2010

Link zum Volltext

Verfügbarkeit prüfen

Cancer and Immune Response: Old and New Evidence for Future Challenges

The oncologist (Dayton, Ohio), 2008-12, Vol.13 (12), p.1246-1254

2008

Link zum Volltext

Verfügbarkeit prüfen

Sunitinib-induced asthenia: From molecular basis to clinical relief

Cancer biology & therapy, 2011-11, Vol.12 (9), p.765-771

2011

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors

Frontiers in endocrinology (Lausanne), 2021-04, Vol.12, p.676973-676973

2021

Link zum Volltext

Verfügbarkeit prüfen

Primary Neuroendocrine Tumor of the Parotid Gland: A Case Report and a Comprehensive Review of a Rare Entity

Case reports in otolaryngology, 2016-01, Vol.2016, p.6971491-5

2016

Link zum Volltext

Verfügbarkeit prüfen

Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity

Anti-cancer drugs, 2012-01, Vol.23 (1), p.1-11

2012

Link zum Volltext

Verfügbarkeit prüfen

Old and New Insights in the Treatment of Thyroid Carcinoma

Journal of Thyroid Research, 2010-01, Vol.2010, p.279468-16

2010

Link zum Volltext

Verfügbarkeit prüfen

Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway

Clinical & translational oncology, 2011-02, Vol.13 (2), p.77-83

2011

Link zum Volltext

Verfügbarkeit prüfen

Melanoma: from darkness to promise

American journal of clinical oncology, 2011-04, Vol.34 (2), p.179-187

2011

Link zum Volltext

Verfügbarkeit prüfen

Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient

Anti-cancer drugs, 2010-01, Vol.21 Suppl 1 (Supplement 1), p.S23-S26

2010

Link zum Volltext

Verfügbarkeit prüfen

Congestive heart failure in a 77-year-old woman receiving adjuvant treatment with imatinib for a large gastric gastrointestinal stromal tumour

Anti-cancer drugs, 2012-06, Vol.23 Imatinib in gastrointestinal stromal tumour (GIST) therapy, p.S15-S17

2012

Link zum Volltext

Verfügbarkeit prüfen

Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

Molecular medicine reports, 2010-07, Vol.3 (4), p.575-580

2010

Link zum Volltext

Verfügbarkeit prüfen

Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms

Clinical & developmental immunology, 2011-01, Vol.2011, p.174149-9

2011

Link zum Volltext

Verfügbarkeit prüfen

New insights into molecular mechanisms of sunitinib-associated side effects

Molecular cancer therapeutics, 2011-12, Vol.10 (12), p.2215-2223

2011

Link zum Volltext

Verfügbarkeit prüfen

Biology of BMP signalling and cancer

Clinical & translational oncology, 2009-03, Vol.11 (3), p.126-137

2009

Link zum Volltext

Verfügbarkeit prüfen

Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies

Clinical & translational oncology, 2006-01, Vol.8 (1), p.50-53

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P024: Antitumoral effect of telotristat ethyl as a single agent in neuroendocrine tumor cell lines and potential synergies

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P024-P024

2021

Link zum Volltext

Verfügbarkeit prüfen

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

Clinical & translational oncology, 2023-09, Vol.25 (9), p.2692-2706

2023

Link zum Volltext

Verfügbarkeit prüfen

PAZONET: Results of a phase II trial of pazopanib as a sequencing treatment in progressive metastatic neuroendocrine tumors (NETs) patients (pts), on behalf of the Spanish task force for NETs (GETNE)—NCT01280201

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4119-4119

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of CYP3A5, VEGF-a , and VEGFR2 polymorphisms as markers of sunitinib toxicity

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10546-10546

2012

Link zum Volltext

Verfügbarkeit prüfen

Cartas al editor

Medicina clínica, 2005-04, Vol.124 (12), p.478

2005

Link zum Volltext

Verfügbarkeit prüfen

PII: S0025-7753(05)71774-7

Medicina clínica, 2005, Vol.124 (12), p.478-478

2005

Link zum Volltext

Verfügbarkeit prüfen

The epidemiology of asymptomatic pulmonary embolism in cancer patients

Medicina clínica, 2004-10, Vol.123 (13), p.516-516

2004

Link zum Volltext

Verfügbarkeit prüfen

Epidemiología de las tromboembolias pulmonares asintomáticas en los enfermos con cáncer

Medicina clínica, 2004-10, Vol.123 (13), p.516-516

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(16)
Oncology
(13)
Antineoplastic Agents - Therapeutic Use
(8)
Cancer
(5)
Female
(5)
Animals
(4)
Indoles - Therapeutic Use
(4)
Male
(4)
Middle Aged
(4)
Pharmacology & Pharmacy
(4)
Pyrroles - Therapeutic Use
(4)
Adult
(3)
Aged
(3)
Angiogenesis
(3)
Angiogenesis Inhibitors - Pharmacology
(3)
Antineoplastic Agents - Adverse Effects
(3)
Endocrinology & Metabolism
(3)
Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib

Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

Cancer and Immune Response: Old and New Evidence for Future Challenges

Sunitinib-induced asthenia: From molecular basis to clinical relief

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors

Primary Neuroendocrine Tumor of the Parotid Gland: A Case Report and a Comprehensive Review of a Rare Entity

Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity

Old and New Insights in the Treatment of Thyroid Carcinoma

Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway

Melanoma: from darkness to promise

Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient

Congestive heart failure in a 77-year-old woman receiving adjuvant treatment with imatinib for a large gastric gastrointestinal stromal tumour

Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms

New insights into molecular mechanisms of sunitinib-associated side effects

Biology of BMP signalling and cancer

Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies

Abstract P024: Antitumoral effect of telotristat ethyl as a single agent in neuroendocrine tumor cell lines and potential synergies

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

PAZONET: Results of a phase II trial of pazopanib as a sequencing treatment in progressive metastatic neuroendocrine tumors (NETs) patients (pts), on behalf of the Spanish task force for NETs (GETNE)—NCT01280201

Evaluation of CYP3A5, VEGF-a , and VEGFR2 polymorphisms as markers of sunitinib toxicity

Cartas al editor

PII: S0025-7753(05)71774-7

The epidemiology of asymptomatic pulmonary embolism in cancer patients

Epidemiología de las tromboembolias pulmonares asintomáticas en los enfermos con cáncer

Suchergebnisse filtern